Supply chains that think,
factories that respond.
We advise pharmaceutical and manufacturing leaders on the intersection of supply chain, digital, and analytics — where strategy meets the shop floor.
A firm built around outcomes, not decks.
A world where every pharmaceutical and manufacturing supply chain is intelligent, resilient, and self-improving.
We see a future where operational data drives every decision, and where digital intelligence turns complex global networks into a source of competitive advantage.
To help operations leaders translate strategy into measurable, sustained performance.
We combine deep supply chain expertise, advanced analytics, and pragmatic digital delivery — and we stay embedded until the KPIs move and hold.
Four practices.
One operating point of view.
We don't hand off decks. We embed with your teams until the KPI moves and stays moved.
Supply Chain Strategy
Network design, S&OP redesign, cost-to-serve, and resilience frameworks that hold up to real-world volatility.
Digital Supply Chain
Control towers, integrated planning platforms, and digital twins — implemented with the operating model to run them.
Advanced Analytics
Demand sensing, inventory optimization, and AI-driven decision support tuned to your data reality.
Operations Excellence
Lean manufacturing, throughput optimization, and continuous improvement anchored in measurable P&L impact.
Deep in the two sectors where operations are the strategy.
Cold-chain integrity, serialization, contract manufacturing orchestration, and launch readiness across regulated markets.
Multi-plant footprint strategy, supplier risk, and connected factory programs that translate MES/ERP data into decisions.
How we work.
Diagnose
Two weeks. Data-driven baseline, not workshops. You get a numbered list of what's broken and what it costs.
Design
Co-created target operating model — process, data, and org — with signed-off business cases before build.
Deliver
We stay through go-live and the first two planning cycles. If the KPI doesn't move, we don't move on.
Programs that shipped,
numbers that held.
Four representative engagements across pharma, industrial, and consumer health — with the metrics that stayed post-handover.